1. Home
  2. SHOP vs NVO Comparison

SHOP vs NVO Comparison

Compare SHOP & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shopify Inc.

SHOP

Shopify Inc.

HOLD

Current Price

$111.62

Market Cap

164.5B

Sector

Technology

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$35.97

Market Cap

172.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOP
NVO
Founded
2004
1923
Country
Canada
Denmark
Employees
N/A
69500
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5B
172.5B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SHOP
NVO
Price
$111.62
$35.97
Analyst Decision
Buy
Hold
Analyst Count
34
11
Target Price
$163.67
$51.00
AVG Volume (30 Days)
7.9M
15.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
3.38%
EPS Growth
N/A
N/A
EPS
0.94
N/A
Revenue
$11,556,000,000.00
N/A
Revenue This Year
$29.32
N/A
Revenue Next Year
$23.70
$3.30
P/E Ratio
$122.77
$13.60
Revenue Growth
30.14
N/A
52 Week Low
$69.84
$35.85
52 Week High
$182.19
$81.44

Technical Indicators

Market Signals
Indicator
SHOP
NVO
Relative Strength Index (RSI) 38.09 30.09
Support Level $104.79 $35.85
Resistance Level $117.36 $39.58
Average True Range (ATR) 4.99 0.85
MACD -1.08 0.33
Stochastic Oscillator 5.21 0.15

Price Performance

Historical Comparison
SHOP
NVO

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: